Gleevec is an oral cancer medication used to treat certain types of leukemia and gastrointestinal stromal tumors by inhibiting abnormal protein activity that promotes cancer cell growth.
Glyxambi is a prescription medication used to control blood sugar in adults with type 2 diabetes. It combines empagliflozin and linagliptin to help regulate glucose levels and support overall glycemic management.